Clinical Trials Browser

Phase 3 × Not yet recruiting × Brentuximab Vedotin × Clear all

NCT07178457 2025-09-17

BeCALM

Phase 3 Not yet recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous